Zamristobart
扎瑞苏拜单抗
Report date: 2026/04/17 20:02:02
Base Information
Drug NameZamristobart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiond Biologics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSanofiThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A